Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. “We feel that a product like an oral, orforglipron, could serve a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback